MRVI vs PCRX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
MRVI
PCRX
Investment Advisor Scores
PCRX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MRVI | PCRX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 370.3704 | 6.25 | PCRX |
| PEG Ratio | 0 | 11.2121 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 8.5% | 6.2% | MRVI |
| Earnings Growth | -32.7% | -30.0% | PCRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 44.4/100 | 55.8/100 | PCRX |
| Profit Margin | -37.1% | 2.0% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MRVI
MarkupPrice above SMA50, rising 50-day trend (4.9% over 20 days), RSI 54
PCRX
DistributionPrice near a flattening SMA50 (slope -0.2%) with fading momentum, RSI 49
Fundamentals Snapshot
| Metric | MRVI | PCRX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -76.4 | 7.3 |
| Trailing P/E | — | 69.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.4% | 0.8% |
| Operating Margin | -0.3% | 0.1% |
| EPS | -0.53 | 0.36 |
| Dividend Yield | — | — |